{"id":9889,"date":"2025-11-03T21:01:17","date_gmt":"2025-11-03T20:01:17","guid":{"rendered":"https:\/\/letscureacc.com\/?post_type=glossary&#038;p=9889"},"modified":"2025-11-03T21:02:40","modified_gmt":"2025-11-03T20:02:40","slug":"immunotherapie","status":"publish","type":"glossary","link":"https:\/\/letscureacc.com\/fr\/glossaryindex\/immunotherapie\/","title":{"rendered":"IMMUNOTH\u00c9RAPIE"},"content":{"rendered":"<p><span data-sheets-root=\"1\">Il s&rsquo;agit de m\u00e9dicaments qui peuvent renforcer le syst\u00e8me immunitaire du corps afin d\u2019identifier et d\u2019\u00e9radiquer les cellules canc\u00e9reuses. L\u2019un de ces m\u00e9dicaments, utilis\u00e9 pour le traitement du corticosurr\u00e9nalome <\/span><span data-sheets-root=\"1\">(ACC en anglais), est le pembrolizumab (nom de marque aux \u00c9tats-Unis : Keytruda\u00ae). Il existe plusieurs types d\u2019immunoth\u00e9rapies contre le cancer, et selon Yale Medicine, elles ciblent diff\u00e9rents m\u00e9canismes. Certaines produisent des anticorps pour attaquer directement les cellules canc\u00e9reuses. D\u2019autres agissent diff\u00e9remment, comme le pembrolizumab, qui am\u00e9liore la capacit\u00e9 du syst\u00e8me immunitaire \u00e0 d\u00e9truire les cellules canc\u00e9reuses. Cette classe d\u2019immunoth\u00e9rapie est appel\u00e9e inhibiteur des points de contr\u00f4le immunitaires.<br \/>\n<\/span><\/p>\n<p>Source: <a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/pembrolizumab\">https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/pembrolizumab<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Il s&rsquo;agit de m\u00e9dicaments qui peuvent renforcer le syst\u00e8me immunitaire du corps afin d\u2019identifier et d\u2019\u00e9radiquer les cellules canc\u00e9reuses. L\u2019un de ces m\u00e9dicaments, utilis\u00e9 pour le traitement du corticosurr\u00e9nalome (ACC en anglais), est le pembrolizumab (nom de marque aux \u00c9tats-Unis : Keytruda\u00ae). Il existe plusieurs&#8230;<\/p>\n","protected":false},"author":416,"featured_media":0,"menu_order":0,"template":"","meta":{"give_campaign_id":0,"inline_featured_image":false,"footnotes":""},"glossary-categories":[],"glossary-tags":[],"class_list":["post-9889","glossary","type-glossary","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/glossary\/9889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/users\/416"}],"version-history":[{"count":0,"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/glossary\/9889\/revisions"}],"wp:attachment":[{"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/media?parent=9889"}],"wp:term":[{"taxonomy":"glossary-categories","embeddable":true,"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/glossary-categories?post=9889"},{"taxonomy":"glossary-tags","embeddable":true,"href":"https:\/\/letscureacc.com\/fr\/wp-json\/wp\/v2\/glossary-tags?post=9889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}